Page last updated: 2024-08-25

zoledronic acid and Cavernous Angioma, Central Nervous System

zoledronic acid has been researched along with Cavernous Angioma, Central Nervous System in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gunel, M; Levchenko, A; Louvi, A; Mishra-Gorur, K; Nishimura, S; Park, J; Sebti, SM; Surovtseva, YV	1

Other Studies

1 other study(ies) available for zoledronic acid and Cavernous Angioma, Central Nervous System

Article	Year
Combined HMG-COA reductase and prenylation inhibition in treatment of CCM. Proceedings of the National Academy of Sciences of the United States of America, 2017, 05-23, Volume: 114, Issue:21 Topics: Animals; Astrocytes; Diphosphonates; Drosophila; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelial Cells; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hemangioma, Cavernous, Central Nervous System; High-Throughput Screening Assays; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Male; MAP Kinase Signaling System; Mice; Pregnancy; Protein Prenylation; Zoledronic Acid	2017

Article

Year

Combined HMG-COA reductase and prenylation inhibition in treatment of CCM.

Proceedings of the National Academy of Sciences of the United States of America, 2017, 05-23, Volume: 114, Issue:21

Topics: Animals; Astrocytes; Diphosphonates; Drosophila; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelial Cells; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hemangioma, Cavernous, Central Nervous System; High-Throughput Screening Assays; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Male; MAP Kinase Signaling System; Mice; Pregnancy; Protein Prenylation; Zoledronic Acid

2017